AIF1 and Alzheimer disease: Because AD brains are characterized by neuronal loss, reactive gliosis, and microglial activation, we also corrected gene expression levels for specific subpopulations of cells (neurons [MAP2], microglia [AIF1], and astrocytes [GFAP]) to determine if there were cell specific effects on gene expression.